Dr. Christina C Kong, MD is a Pathologist - Anatomic Pathology & Clinical Pathology practicing in Stanford, CA
She has not yet shared a personalized biography with Doctor.com.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| University of California | Medical Degree | 1992 | |
| University of Ca, San Francisco, School of Medicine, San Francisco Ca | Other Degree | 1992 |
| Institution | Focus | Year |
|---|---|---|
| Internship - U Calif | Not Specified | |
| Internship - University of California San Francisco, San Francisco CA | 1993 | |
| Internship - University of California San Francisco CA | 1993 | |
| Residency - University Ca Sf School of Medicine, Anatomic And Clinical Pathology; University Ca Sf School of Medicine, Cytopathology; University Ca Sf School of Medicine, Internal Medicine | Not Specified | |
| Fellowship - UCSF Medical Center CA | 1998 | |
| Fellowship - Stanford University School of Medicine CA | 1997 | |
| Fellowship - Stanford University School of Medicine, Stanford CA | 1997 | |
| Fellowship - UCSF Medical Center, San Francisco CA | 1998 |
| Certification | Cert. Body | Year |
|---|---|---|
| Anatomic Pathology | Pathology | 2014 |
| Anatomic Pathology Sub-Specialty: Cytopathology | Pathology | 2000 |
| Clinical Pathology | Pathology | 1999 |
| Anatomic Pathology/Clinical Pathology Sub-Specialty: Cytopathology | Pathology | Not Specified |
| Position | Organization | Time |
|---|---|---|
| Acting Director | Cytopathology Laboratory | 2004 - 2005 |
| Associate Director | Cytopathology Laboratory | 2002 - 2003 |
| Director | Cytopathology Laboratory | 2006 - 2014 |
| Director | Cytopathology Fellowship | 2003 - 2014 |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | LARYNGOSCOPE | Long-Term Outcomes of Surgery Followed by Radiation Therapy for Minor Salivary Gland Carcinomas | 2013 |
| Other Publication | Clinical cancer research | A novel aldehyde dehydrogese-3 activator | 2013 |
| Other Publication | AMERICAN JOURL OF SURGICAL PATHOLOGY | p16 Is Superior to ProEx C in Identifying High-grade Squamous Intraepithelial Lesions | 2013 |
| Other Publication | ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | Laboratory-Developed L1 Sequencing and Type-Specific | 2013 |
| Other Publication | ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY | Loss of the p53/p63 target PERP | 2013 |
| Other Publication | Oral surgery, oral medicine, oral pathology and oral radiology | Loss of the p53/p63 target PERP | 2013 |
| Other Publication | INTERTIOL FORUM OF ALLERGY & RHINOLOGY | CD44+cells have cancer stem cell-like properties in sopharyngeal carcinoma | 2012 |
| Other Publication | JOURL OF SURGICAL ONCOLOGY | The diagnostic value of nipple discharge cytology | 2012 |
| Other Publication | INTERTIOL JOURL OF GYNECOLOGICAL PATHOLOGY | Are Women With Endocervical Adenocarcinoma at Risk for Lynch Syndrome? Evaluation of 101 C | 2012 |
| Other Publication | AMERICAN JOURL OF SURGICAL PATHOLOGY | Evaluation of ProExC as a Prognostic Marker in Oropharyngeal Squamous Cell Carcinomas | 2012 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Validation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer | 2012 |
| Other Publication | CLINICAL CANCER RESEARCH | Prognostic and Predictive Significance of Plasma HGF and IL | 2012 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Quantitation of Human Papillomavirus D in Plasma of Oropharyngeal Carcinoma Patients | 2012 |
| Other Publication | RADIOTHERAPY AND ONCOLOGY | Correlation between metabolic tumor volume | 2011 |
| Other Publication | CLINICAL CANCER RESEARCH | A Novel Aldehyde Dehydrogese-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo | 2011 |
| Other Publication | CANCER RESEARCH | Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis | 2011 |
| Other Publication | AMERICAN JOURL OF DERMATOPATHOLOGY | Differentiated (Simplex) Vulvar Intraepithelial Neoplasia | 2011 |
| Other Publication | AMERICAN JOURL OF SURGICAL PATHOLOGY | MYB Expression and Translocation | 2011 |
| Other Publication | AMERICAN JOURL OF SURGICAL PATHOLOGY | A Panel of 3 Markers Including p16, ProExC | 2010 |
| Other Publication | PLOS ONE | The RGD Domain of Human Osteopontin Promotes Tumor Growth | 2010 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival | 2009 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | THE RELATIONSHIP BETWEEN HUMAN PAPILLOMAVIRUS STATUS AND OTHER MOLECULAR PROGNOSTIC MARKERS IN HEAD | 2009 |
| Other Publication | CANCER CYTOPATHOLOGY | p16(INK4A) Immunohistochemical Staining May Be Helpful in Distinguishing Branchial Cleft Cysts From | 2009 |
| Other Publication | ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | Pathology Quiz Case Cholesterol granuloma (CG) of the left maxillary sinus | 2008 |
| Other Publication | CANCER CYTOPATHOLOGY | Cytologic Evaluation of Lymphadenopathy Associated With Mycosis Fungoides | 2008 |
| Other Publication | ADVANCES IN ATOMIC PATHOLOGY | Diagnostic problems in al pathology | 2008 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Expression and prognostic significance of a panel of tissue hypoxia markers in head-and | 2007 |
| Other Publication | AMERICAN JOURL OF SURGICAL PATHOLOGY | Role of human papillomavirus in squamous cell metaplasia-dysplasia-carcinoma of the rectum | 2007 |
| Other Publication | DIAGNOSTIC CYTOPATHOLOGY | Cytologic diagnosis of columr-cell lesions of the breast | 2007 |
| Other Publication | AMERICAN JOURL OF SURGICAL PATHOLOGY | p16(INK4A) immunohistochemistry is superior to HPV in situ hybridization for the detection of high | 2007 |
| Other Publication | THYROID | Burkitt's lymphoma presenting as a rapidly growing thyroid mass | 2006 |
| Other Publication | TURE | Lysyl oxidase is essential for hypoxia-induced metastasis | 2006 |
| Other Publication | CLINICAL CANCER RESEARCH | An evaluation of tumor oxygetion | 2006 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Galectin-1: A link between tumor hypoxia and tumor immune privilege | 2005 |
| Other Publication | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | Utility of syndecan-1 | 2005 |
| Other Publication | Cancer | Cytologic diagnosis of Burkitt lymphoma. | 2005 |
| Other Publication | AMERICAN JOURL OF SURGERY | Pathologic correlates of false positive breast magnetic resonce imaging findings | 2005 |
| Other Publication | INTERTIOL JOURL OF GYNECOLOGICAL PATHOLOGY | Endometrial adenocarcinoma associated with subtle lymph-vascular space invasion | 2005 |
| Other Publication | CANCER RESEARCH | Identification of hypoxia | 2004 |
| Other Publication | ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | Laryngeal embryol rhabdomyosarcoma - A case of cervical metastases 13 years after treatment | 2004 |
| Other Publication | ACTA CYTOLOGICA | Nodular fasciitis - Diagnosis by fine needle aspiration biopsy | 2004 |
| Other Publication | THYROID | Ectopic intrathyroidal thymoma: A case report and review | 2003 |
| Other Publication | AMERICAN JOURL OF SURGICAL PATHOLOGY | Epithelioid trophoblastic tumor of the uterus in a postmenopausal woman - A case report | 2000 |
| Other Publication | ACTA CYTOLOGICA | Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine | 2000 |
| Other Publication | TRANSPLANTATION | INDUCTION OF DONOR-SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS IN RATS BY PRETRANSPLANT ANTI | 1990 |
| Other Publication | TRANSPLANTATION | USE OF ANTI-L3T4 AND ANTI-IA TREATMENTS FOR PROLONGATION OF XENOGENEIC ISLET TRANSPLANTS | 1988 |
Dr. Christina C Kong, MD has not yet indicated the hospitals that she is affiliated with.
Anatomic Pathology & Clinical Pathology
Years In Practice: 25 (started in 1999)
Accepts New Patients: Yes
Dr. Christina C Kong, MD has not yet listed the medications that she commonly prescribes.
Dr. Christina C Kong, MD has not yet added any information about her practice's billing policies and payment options.
